SecBot SecBot

PGEN

PRECIGEN, INC.
Nasdaq· Pharmaceutical Preparations· Inc. VA· CIK 0001356090 Biotech & Drug Discovery
$4.30 −0.24 (−5.29%)
Nov 16 4:00 PM ET · prev $4.54
Market cap
$1.7B
Small cap
Consensus
Buy
80% Buy or better · 10 analysts
Median target
$12.00
+179% · range $11.00–18.00
1 year
−12.2%
from $4.90 · Nov 17
30 days
−35.4%
from $6.66
52-week range
$3.10–8.56
−50% from high · low Mar 25
Avg volume 20D
7.88M
Nov 5 spike 26.65M
Short interest
44.91M
≈12.5% of shares · −3.2%
Days to cover
8.6
at average volume
Insider net
−$7.9M
1 buyer · 6 sellers · since Apr 20
New fund stakes
1
Q3 2026 13F · 0 exits
Filing reports
13
analyzed by SecBot
SecBot read BULLISH 5 reports · 90 days
Balance 1 bearish · 1 bullish · 3 neutral oldest → newest, height = score
Avg score ·High conf. 2/5

Price

Daily candles with volume. Callouts mark insider and congressional trades, rating changes, 13F stakes, reports, catalysts, court and regulator actions, Reddit spikes and short-interest jumps. Hover one for the details (tap on phones).

Signal stack

Where each data set points today.

  • InsidersBEARISH

    1 insider bought $24.7K at an average $7.23. 6 insiders sold $8.0M. Price is 41% below their cost.

  • InstitutionsBULLISH

    Q3 2026: 32 added (1 new), 14 trimmed or exited. Largest new: Qube Research & Technologies $18.9M.

  • AnalystsBULLISH

    8 of 10 rate it Buy or better. Every target is above the price.

  • EstimatesRISING

    Current-quarter EPS estimate $0.110 → $0.114 over 90 days. 2 up, 1 down in 30 days.

  • Short sellersSTEADY

    Short interest −3.2% to 44.91M shares. 8.6 days to cover, ≈12.5% of shares.

  • TrendDOWNTREND

    36% below its 50-day average.

  • SocialQUIET

    No Reddit mentions this week. Last mention Nov 4.

Who's buying

13F· Q3 2026
1
new positions
0
exits
$18.9M
in new stakes
FundMoveSharesValue
FMR LLCADD3,913,408$33.5M
FIRST TRUST ADVISORS LPADD2,623,975$22.5M
Nuveen, LLCDOUBLED2,418,938$20.7M
ARROWSTREET CAPITAL, LIMITED PARTNERSHIPADD2,335,271$20.0M
Qube Research & Technologies LtdNEW2,208,964$18.9M
UBS Group AGDOUBLED1,574,677$13.5M
BARCLAYS PLCADD1,354,948$11.6M
VICTORY CAPITAL MANAGEMENT INCDOUBLED683,268$5.8M

Quarterly 13F filings are due 45 days after each quarter ends.

The Street

10 analysts
Buy 80% rate it Buy or better
Strong Buy2Buy6Hold2Sell0Strong Sell0
12-month targets · 3 analysts

Price is below the lowest target. Median implies +179%.Targets as of Nov 17, 2026.

Recent actions
DateFirmActionRating
Nov 16, 2026🔒 Fresh data, subscribers only
REITERATE
REITERATE
Nov 5, 2026Citizens
MAINTAIN
MAINTAINMarket Outperform
Sep 25, 2026B. Riley Securities
INITIATE
INITIATEBuy
Aug 5, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy
Aug 3, 2026HC Wainwright & Co.
REITERATE
REITERATEBuy
May 28, 2026HC Wainwright & Co.
MAINTAIN
MAINTAINBuy

Insider ledger

Form 4
$24.7K
bought · 1 insider
$8.0M
sold · 6 insiders
−40.5%
vs their $7.23 cost
DateInsiderTypeValue
Sep 23, 2026
Thomasian Harry Jr.
Chief Financial Officer
Sep 23, 2026
EXERCISE$100.0K
Sep 23, 2026
Thomasian Harry Jr.
Chief Financial Officer
Sep 23, 2026
EXERCISE$1.92
Sep 23, 2026
Thomasian Harry Jr.
Chief Financial Officer
Sep 23, 2026
EXERCISE$50.7K
Sep 23, 2026
Thomasian Harry Jr.
Chief Financial Officer
Sep 23, 2026
EXERCISE$1.21
Aug 26, 2026
KINDLER JEFFREY B
Director
Aug 26, 2026
SELL$1.4M
Aug 25, 2026
Tennant Phil
Chief Commercial Officer
Aug 25, 2026
EXERCISE$127.5K
Aug 25, 2026
Shah Rutul R
Chief Operating Officer
Aug 25, 2026
SELL$115.1K
Aug 25, 2026
Shah Rutul R
Chief Operating Officer
Aug 25, 2026
EXERCISE$35.7K

Earnings setup

Estimates
$0.11
EPS estimate, this quarter
+3%
estimate change, 90 days
2↑ 1↓
revisions, 30 days
Current-quarter EPS estimate
PeriodEPS est.Range30D rev.Revenue
Current Q$0.11$0.10–$0.13+3.4%$87.9M
Next Q$0.14$0.11–$0.17-19.6%$92.6M
Current FY🔒 Fresh data, subscribers only
Next FY$0.62$0.43–$0.95-1.5%$442.0M
Reddit
Recent posts
All social signals and their track records

Short side

FINRA· Oct 30, 2026
44,908,434
shares short
-3.2%
vs prior settlement
8.6
days to cover
≈12.5%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Nov 11, 2026 Earnings calendar
PGEN Q3 2026 Earnings Scheduled · 2026-11-11
Nov 4, 2026 SEC
Precigen reported Q3 2026 revenue of $74.1M (vs. $71.6M consensus) and GAAP diluted EPS of $0.08 (in line with…
8-K · Impact 6/10
Sep 30, 2026 Inst.
FMR LLC · ADD
3,913,408 shares ($33.5M)
Sep 30, 2026 Inst.
FIRST TRUST ADVISORS LP · ADD
2,623,975 shares ($22.5M)
Sep 23, 2026 Insider
Thomasian Harry Jr. acquired via exercise 42,918 shares
Chief Financial Officer @ $2.33 ($100.0K)
Sep 23, 2026 Insider
Thomasian Harry Jr. acquired via exercise 2 shares
Chief Financial Officer @ $0.9600 ($1.92)
Sep 23, 2026 Insider
Thomasian Harry Jr. acquired via exercise 10,744 shares
Chief Financial Officer @ $4.72 ($50.7K)
Aug 28, 2026 SEC
A mixed insider cluster at Precigen shows a director selling $1.38M in open-market shares and the CCO selling $594K…
CLUSTER · Impact 3/10
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
1 drug tracked · Drug pipeline →
Recent

SecBot reports

13 filings · 2 bullish · 2 bearish · 9 neutral
All PGEN filing & press-release reports (13)